These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 33300484)
1. How concerned should we be about neurotropism of SARS-Cov-2? A brief clinical consideration of the possible psychiatric implications. De Berardis D CNS Spectr; 2022 Jun; 27(3):258-259. PubMed ID: 33300484 [No Abstract] [Full Text] [Related]
2. COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2? Liang F; Wang Y Viruses; 2021 Nov; 13(11):. PubMed ID: 34835030 [TBL] [Abstract][Full Text] [Related]
3. Pathways and Pathogenesis of Hearing Deficits, Tinnitus, and Vertigo in COVID-19. Baig AM ACS Chem Neurosci; 2021 Dec; 12(23):4368-4370. PubMed ID: 34780147 [TBL] [Abstract][Full Text] [Related]
4. [Neuropsychological long-COVID : neurologic or psychiatric origin?]. Benzakour L; Assal F; Péron JA Rev Med Suisse; 2021 Apr; 17(736):822-826. PubMed ID: 33908718 [TBL] [Abstract][Full Text] [Related]
5. Emerging neurotropic features of SARS-CoV-2. Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037 [TBL] [Abstract][Full Text] [Related]
6. Neurotropism and Neuropsychiatric Symptomsi in Patients with COVID-19. Moretti P; Brufani F; Pierotti V; Pomili G; Di Buò A; Giulietti C; Masini F; Tanku V; Bachetti MC; Menculini G; Tortorella A Psychiatr Danub; 2021 Dec; 33(Suppl 11):10-13. PubMed ID: 34862882 [TBL] [Abstract][Full Text] [Related]
7. COVID-19, SARS -CoV-2, Origin, Transmission and Treatment Aspects, A Brief Review. Nawaz S Infect Disord Drug Targets; 2021; 21(5):e270421186673. PubMed ID: 33023459 [TBL] [Abstract][Full Text] [Related]
8. An Outbreak of Breakthrough Infections by the SARS-CoV-2 Delta Variant in a Psychiatric Closed Ward. Wi YM; Kim SH; Peck KR J Korean Med Sci; 2022 Jan; 37(4):e28. PubMed ID: 35075827 [TBL] [Abstract][Full Text] [Related]
10. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19. Baig AM ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045 [TBL] [Abstract][Full Text] [Related]
11. Current Perspective of COVID-19 on Neurology: A Mechanistic Insight. Kumar R; Harilal S; M S; Pappachan LK; P R R; Mathew B Comb Chem High Throughput Screen; 2022; 25(5):763-767. PubMed ID: 34353250 [TBL] [Abstract][Full Text] [Related]
12. Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2. Bullen CK; Hogberg HT; Bahadirli-Talbott A; Bishai WR; Hartung T; Keuthan C; Looney MM; Pekosz A; Romero JC; Sillé FCM; Um P; Smirnova L ALTEX; 2020; 37(4):665-671. PubMed ID: 32591839 [TBL] [Abstract][Full Text] [Related]
13. Xerostomia and Taste Alterations in COVID-19. Belchior Fontenele MN; Pedrosa MDS Ear Nose Throat J; 2021 Apr; 100(2_suppl):186S-187S. PubMed ID: 33356523 [TBL] [Abstract][Full Text] [Related]
14. Role of SARS-CoV-2 neurotropism and neuroinvasion in COVID-19 patients disease severity. Grijalva-Otero I Gac Med Mex; 2020; 156(4):339-343. PubMed ID: 32831327 [TBL] [Abstract][Full Text] [Related]
15. The role of neurotropism in psychiatric patients with COVID-19. Diaz AD; Baweja R Eur Arch Psychiatry Clin Neurosci; 2021 Mar; 271(2):385-386. PubMed ID: 32980914 [No Abstract] [Full Text] [Related]
16. The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys. Jiao L; Yang Y; Yu W; Zhao Y; Long H; Gao J; Ding K; Ma C; Li J; Zhao S; Wang H; Li H; Yang M; Xu J; Wang J; Yang J; Kuang D; Luo F; Qian X; Xu L; Yin B; Liu W; Liu H; Lu S; Peng X Signal Transduct Target Ther; 2021 Apr; 6(1):169. PubMed ID: 33895780 [TBL] [Abstract][Full Text] [Related]
17. Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2. ElBini Dhouib I Drug Discov Ther; 2021 Jan; 14(6):262-272. PubMed ID: 33390561 [TBL] [Abstract][Full Text] [Related]
18. [MicroRNAs as the Potential Regulators of SARS-CoV-2 Infection and Modifiers of the COVID-19 Clinical Features]. Kucher AN; Koroleva IA; Zarubin AA; Nazarenko MS Mol Biol (Mosk); 2022; 56(1):35-54. PubMed ID: 35082257 [TBL] [Abstract][Full Text] [Related]
19. COVID-19 and Neurology: An Emerging Association. Gupta A; Yadav P; Kumar D Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080 [TBL] [Abstract][Full Text] [Related]
20. COVID-19: what if the brain had a role in causing the deaths? Tassorelli C; Mojoli F; Baldanti F; Bruno R; Benazzo M Eur J Neurol; 2020 Sep; 27(9):e41-e42. PubMed ID: 32333819 [No Abstract] [Full Text] [Related] [Next] [New Search]